BETAHISTINE-ZP betahistine dihydrochloride 8mg tablets blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

betahistine dihydrochloride, Quantity: 8 mg

Commercializzato da:

Medis Pharma Pty Ltd

INN (Nome Internazionale):

betahistine dihydrochloride

Forma farmaceutica:

Tablet

Composizione:

Excipient Ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose

Via di somministrazione:

Oral

Confezione:

100 tablets, 10 tablets, 25 tablets

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Dettagli prodotto:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B8 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2015-11-10